Literature DB >> 25432899

Inflammation and hypertension: new understandings and potential therapeutic targets.

Carmen De Miguel1, Nathan P Rudemiller, Justine M Abais, David L Mattson.   

Abstract

Research studying the role of inflammation in hypertension and cardiovascular disease has flourished in recent years; however, the exact mechanisms by which the activated immune cells lead to the development and maintenance of hypertension remain to be elucidated. The objectives of this brief review are to summarize and discuss the most recent findings in the field, with special emphasis on potential therapeutics to treat or prevent hypertension. This review will cover novel immune cell subtypes recently associated to the disease including the novel role of cytokines, toll-like receptors, and inflammasomes in hypertension.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25432899      PMCID: PMC4418473          DOI: 10.1007/s11906-014-0507-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  99 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Authors:  Modar Kassan; Maria Galan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 3.  Brain dendritic cells: biology and pathology.

Authors:  Paul M D'Agostino; Andres Gottfried-Blackmore; Niroshana Anandasabapathy; Karen Bulloch
Journal:  Acta Neuropathol       Date:  2012-07-24       Impact factor: 17.088

4.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia.

Authors:  Styliani Goulopoulou; Takayuki Matsumoto; Gisele F Bomfim; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

6.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.

Authors:  Zhongyang Lu; Xiaoming Zhang; Yanchun Li; Junfei Jin; Yan Huang
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

8.  Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2.

Authors:  Johannes Ruef; Michael Browatzki; Caroline A H Pfeiffer; Joachim Schmidt; Roger Kranzhöfer
Journal:  Vasc Med       Date:  2007-02       Impact factor: 3.239

9.  Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.

Authors:  Pierre-Jean Saulnier; Elise Gand; Stéphanie Ragot; Grégory Ducrocq; Jean-Michel Halimi; Charlotte Hulin-Delmotte; Pierre Llaty; David Montaigne; Vincent Rigalleau; Ronan Roussel; Gilberto Velho; Philippe Sosner; Philippe Zaoui; Samy Hadjadj
Journal:  Diabetes Care       Date:  2014-03-12       Impact factor: 19.112

10.  Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study.

Authors:  Katharina Paul; Daniel Kretzschmar; Atilla Yilmaz; Barbara Bärthlein; Stephanie Titze; Gunter Wolf; Martin Busch
Journal:  BMC Nephrol       Date:  2013-12-10       Impact factor: 2.388

View more
  69 in total

1.  The receptor tyrosine kinase EPHB6 regulates catecholamine exocytosis in adrenal gland chromaffin cells.

Authors:  Wei Shi; Bei Ye; Marion Rame; Yujia Wang; Dominique Cioca; Sophie Reibel; Junzheng Peng; Shijie Qi; Nicolas Vitale; Hongyu Luo; Jiangping Wu
Journal:  J Biol Chem       Date:  2020-04-22       Impact factor: 5.157

Review 2.  Immune cell trafficking, lymphatics and hypertension.

Authors:  Dakshnapriya Balasubbramanian; Catalina A Lopez Gelston; Joseph M Rutkowski; Brett M Mitchell
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

3.  Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Authors:  Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-08

Review 4.  Immunity in arterial hypertension: associations or causalities?

Authors:  Hans-Joachim Anders; Marcus Baumann; Giovanni Tripepi; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2015-03-11       Impact factor: 5.992

5.  Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.

Authors:  Ming-Zhi Zhang; Bing Yao; Yinqiu Wang; Shilin Yang; Suwan Wang; Xiaofeng Fan; Raymond C Harris
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

6.  Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.

Authors:  Luca Liberale; Fabrizio Montecucco; Jean-Claude Tardif; Peter Libby; Giovanni G Camici
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

7.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869

8.  Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies.

Authors:  Ahmad Jayedi; Kazem Rahimi; Leonelo E Bautista; Milad Nazarzadeh; Mahdieh Sadat Zargar; Sakineh Shab-Bidar
Journal:  Heart       Date:  2019-01-30       Impact factor: 5.994

9.  Interleukin-10 negatively modulates extracellular signal-regulated kinases 1 and 2 in aorta from hypertensive mouse induced by angiotensin II infusion.

Authors:  Alecsander F Bressan; Gisele A Fonseca; Rita C Tostes; R Clinton Webb; Victor Vitorino Lima; Fernanda Regina Giachini
Journal:  Fundam Clin Pharmacol       Date:  2018-09-07       Impact factor: 2.748

10.  Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.

Authors:  Todd M Gibson; Zhenghong Li; Daniel M Green; Gregory T Armstrong; Daniel A Mulrooney; DeoKumar Srivastava; Nickhill Bhakta; Kirsten K Ness; Melissa M Hudson; Leslie L Robison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-22       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.